Current Ratio in % of C4 Therapeutics, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
C4 Therapeutics, Inc. quarterly Current Ratio history and change rate from Q2 2021 to Q3 2025.
  • C4 Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 554 %, a 1.65% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

C4 Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 554 -9.3 -1.65% Sep 30, 2025
Q2 2025 569 -7.6 -1.32% Jun 30, 2025
Q1 2025 567 -28.4 -4.77% Mar 31, 2025
Q4 2024 550 -102 -15.7% Dec 31, 2024
Q3 2024 563 -91.8 -14% Sep 30, 2024
Q2 2024 576 -80.7 -12.3% Jun 30, 2024
Q1 2024 595 -95 -13.8% Mar 31, 2024
Q4 2023 652 -22.5 -3.34% Dec 31, 2023
Q3 2023 655 -15.9 -2.37% Sep 30, 2023
Q2 2023 657 -47 -6.67% Jun 30, 2023
Q1 2023 690 -105 -13.2% Mar 31, 2023
Q4 2022 675 -171 -20.2% Dec 31, 2022
Q3 2022 671 -243 -26.6% Sep 30, 2022
Q2 2022 704 -135 -16.1% Jun 30, 2022
Q1 2022 795 Mar 31, 2022
Q4 2021 846 Dec 31, 2021
Q3 2021 914 Sep 30, 2021
Q2 2021 839 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.